Anna R. Mislang

Bedford Park, 
Adelaide, SA, AU 
Bedford Park, 
Adelaide, SA, AU 

Overview

Anna Mislang practices practicing medicine in Adelaide, Australia.

Her clinical expertise encompasses Scrotal Masses, COVID-19, Severe Acute Respiratory Syndrome (SARS), Lymphofollicular Hyperplasia, and Orchiectomy.

She is actively involved in clinical research, co-authoring 26 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Bedford Park, Adelaide, SA, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1a/1b, Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK112 in Subjects With Advanced Solid Tumors
A Phase 1a/1b, Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK112 in Subjects With Advanced Solid Tumors
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Multicenter, Open Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104 in Subjects With Relapsed/Refractory Advanced or Metastatic Solid Tumors or Lymphomas
A Phase 1 Multicenter, Open Label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104 in Subjects With Relapsed/Refractory Advanced or Metastatic Solid Tumors or Lymphomas
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

26 Total Publications

Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro).
Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro).
Journal: ESMO real world data and digital oncology
Published: February 27, 2026

Frequently Asked Questions about Anna R. Mislang

Is Anna R. Mislang a top-rated expert for Scrotal Masses?

MediFind is an objective health platform that identifies experts based on real-world data. Anna R. Mislang is classified as an Experienced expert for Scrotal Masses, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anna R. Mislang participate in research or clinical trials?

Yes. Anna R. Mislang has published 26 articles and abstracts on conditions like Scrotal Masses. You can view a list of Anna R. Mislang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mislang's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile